[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide

C57H106N2O9 — CID 158034856

IUPAC[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide
SMILESCCCCCCCCCCC(=O)NCCCOCC(O)CCOCC.CCOCCOCCOCCCNC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C37H65NO5.C20H41NO4/c1-7-40-22-23-42-25-24-41-21-9-20-38-35(39)43-30-16-18-36(5)29(26-30)12-13-31-33-15-14-32(28(4)11-8-10-27(2)3)37(33,6)19-17-34(31)36;1-3-5-6-7-8-9-10-11-13-20(23)21-15-12-16-25-18-19(22)14-17-24-4-2/h12,27-28,30-34H,7-11,13-26H2,1-6H3,(H,38,39);19,22H,3-18H2,1-2H3,(H,21,23)/t28-,30+,31?,32-,33?,34?,36+,37-;/m1./s1
InChIKeyFHPWDQASGGWLFK-GYFLXMTGSA-N
MW963.48 g/mol
LogP12.41
Rot. Bonds36

About [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide

[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide (PubChem CID 158034856) has the molecular formula C57H106N2O9 and a molecular weight of 963.48 g/mol. Its IUPAC name is [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide.

Molecular Properties

Compound Name[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide
PubChem CID158034856
Molecular FormulaC57H106N2O9
Molecular Weight963.48 g/mol
Exact Mass962.79
IUPAC Name[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide
SMILESCCCCCCCCCCC(=O)NCCCOCC(O)CCOCC.CCOCCOCCOCCCNC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C37H65NO5.C20H41NO4/c1-7-40-22-23-42-25-24-41-21-9-20-38-35(39)43-30-16-18-36(5)29(26-30)12-13-31-33-15-14-32(28(4)11-8-10-27(2)3)37(33,6)19-17-34(31)36;1-3-5-6-7-8-9-10-11-13-20(23)21-15-12-16-25-18-19(22)14-17-24-4-2/h12,27-28,30-34H,7-11,13-26H2,1-6H3,(H,38,39);19,22H,3-18H2,1-2H3,(H,21,23)/t28-,30+,31?,32-,33?,34?,36+,37-;/m1./s1
InChIKeyFHPWDQASGGWLFK-GYFLXMTGSA-N
XLogP12.41
TPSA133.81 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds36
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500963.48
LogP ≤ 512.41
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide?
The IUPAC name of [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide (CID 158034856) is [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide.
What is the SMILES notation for [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide?
The canonical SMILES for [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide is CCCCCCCCCCC(=O)NCCCOCC(O)CCOCC.CCOCCOCCOCCCNC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1.
What is the InChIKey of [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide?
The InChIKey is FHPWDQASGGWLFK-GYFLXMTGSA-N. The full InChI is InChI=1S/C37H65NO5.C20H41NO4/c1-7-40-22-23-42-25-24-41-21-9-20-38-35(39)43-30-16-18-36(5)29(26-30)12-13-31-33-15-14-32(28(4)11-8-10-27(2)3)37(33,6)19-17-34(31)36;1-3-5-6-7-8-9-10-11-13-20(23)21-15-12-16-25-18-19(22)14-17-24-4-2/h12,27-28,30-34H,7-11,13-26H2,1-6H3,(H,38,39);19,22H,3-18H2,1-2H3,(H,21,23)/t28-,30+,31?,32-,33?,34?,36+,37-;/m1./s1.
What are the key properties of [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide?
[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide has a molecular weight of 963.48 g/mol, XLogP of 12.41, 36 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[3-[2-(2-ethoxyethoxy)ethoxy]propyl]carbamate;N-[3-(4-ethoxy-2-hydroxybutoxy)propyl]undecanamide is sourced from PubChem (CID 158034856), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).